BXP, Inc. (NYSE: BXP) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). Including properties owned by unconsolidated joint ventures, BXP's portfolio totals 53.3 million square feet and 185 properties, including seven properties under construction/redevelopment.

BXP Inc.

Botanix Pharmaceuticals Limited ( ($AU:BOT) ) just unveiled an announcement. Botanix Pharmaceuticals reported strong growth for the June quarter, w...

Botanix boosts Sofdra sales, tightens costs and fortifies IP as cash position strengthens

Barclays analyst Brendan Lynch maintained a Buy rating on BXP today and set a price target of $79.00. Lynch covers the Real Estate sector, focusing...

BXP (BXP) Receives a Buy from Barclays

Piper Sandler analyst Alexander Goldfarb maintained a Buy rating on BXP today and set a price target of $75.00. According to TipRanks, Goldfarb is ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BXP	$69.21	+0.14%	1.74M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BXP	$69.21	+0.1%	1.74M
3
4
5
6

BXP

BXP

Get BXP Inc. Data in Excel

Get BXP Inc. Data in Excel